Hilary Kramer
Look No Further for The New FANG than Today’s Update
Big Tech has gotten so huge that all it takes is a few Silicon Valley giants nudging into trillion-dollar territory to keep the S&P 500 on its record-breaking trajectory. If you haven’t updated your portfolio since 2015, that’s great news. We have plenty of great news to share with you today. Apple Inc. (NASDAQ:AAPL) is […]
Cannabis Corner: At Last, the Divergence
After months, the moment of truth is at hand. The Big Cannabis stocks that traded in unison are finally going in separate directions. Investors can recognize that they’re different companies. Aurora Cannabis Inc. (NYSE:ACB) and Tilray Inc. (NASDAQ:TLRY) are still trailing the pack. Wall Street just isn’t convinced that these companies have what it takes […]
Trade Truce Doesn’t Make China Stocks a Buy
After months of negotiations and setbacks, an initial trade deal with China is close. That’s good news. When it happens, I’ll cheer. But even if there’s a breakthrough this weekend, it probably won’t play out the way a lot of investors hope. The concessions both sides are willing to make simply don’t add up to […]
Cannabis Corner: When Do These Stocks Get ‘Cheap?’
Investment expert Hilary Kramer reveals a hand-picked stock she thinks can do well despite the latest earnings results
Dig Beneath the Uber Debacle and IPOs Still Have the Edge
Wall Street analyst Hilary Kramer reveals the latest happens surrounding initial public offerings.
Going From Plant to Pharma
Hilary Kramer discusses how cannabis is going from plant to pharmaceuticals. She then explains how investors can profit from this move.